Peter Douglass

Peter Douglass has a diverse work experience in the field of clinical operations and development. Peter started their career at Beth Israel Deaconess Medical Center as a Research Student in 2010. Peter then joined Brigham and Women's Hospital as a Research Coordinator in 2012, where they stayed until 2015. Peter then joined the Dana-Farber Cancer Institute as a Senior Regulatory Coordinator from 2015 to 2016.

In 2016, they joined Biogen as a Clinical Trial Coordinator and later became a Senior Clinical Trial Coordinator in 2017. Peter transitioned to Sage Therapeutics in 2018, where they took on the role of a Sr. Clinical Coordinator until 2020. Peter then progressed to become an Associate Manager in Clinical Operations & Development until September 2021. From September 2021 to April 2023, Peter worked as a Manager in Clinical Operations & Development at Sage Therapeutics.

Currently, Peter holds the position of Senior Manager in Clinical Operations & Development at Sage Therapeutics, where they have been since April 2023.

Peter Douglass holds a Bachelor of Science (BS) degree in Human Physiology from Boston University. Additionally, they have obtained certifications in the MDS-UPDRS Training Program from the International Parkinson and Movement Disorder Society in March 2014. Peter also holds a certification in Medidate RAVE from Medidata Solutions, although the specific month and year of its acquisition are not provided.